WVE

12.85

6.00% -0.82

Handel nachbörslich: 12.85

Wave Life Sciences Ltd (WVE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt WVE? Forum Prognose

Schlusskurs vom Vortag:

$13.67

Offen:

$13.75

24-Stunden-Volumen:

1.68M

Relative Volume:

0.97

Marktkapitalisierung:

$2.05B

Einnahmen:

$113.31M

Nettoeinkommen (Verlust:

$-57.51M

KGV:

-9.4485

EPS:

-1.36

Netto-Cashflow:

$-20.55M

1W Leistung:

-21.84%

1M Leistung:

-16.07%

6M Leistung:

+105.27%

1J Leistung:

+133.21%

1-Tages-Spanne:

$12.76

$13.78

1-Wochen-Bereich:

$12.76

$16.71

52-Wochen-Spanne:

$3.50

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Firmenname

Wave Life Sciences Ltd

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

617-949-2900

Adresse

7 STRAITS VIEW, SINGAPORE

Mitarbeiter

268

Twitter

@WAVELifeSci

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

WVE's Discussions on Twitter

Vergleichen Sie WVE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
WVE	12.85	2.05B	113.31M	-57.51M	-20.55M	-1.36
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-09-27	Fortgesetzt	JP Morgan	Overweight
2024-09-19	Eingeleitet	B. Riley Securities	Buy
2024-09-09	Eingeleitet	JP Morgan	Overweight
2024-05-15	Eingeleitet	Wells Fargo	Overweight
2023-12-19	Hochstufung	Leerink Partners	Market Perform → Outperform
2023-07-05	Eingeleitet	Raymond James	Outperform
2023-05-24	Herabstufung	Jefferies	Buy → Hold
2020-12-15	Fortgesetzt	H.C. Wainwright	Buy
2020-10-23	Eingeleitet	RBC Capital Mkts	Sector Perform
2019-12-31	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Eingeleitet	Guggenheim	Buy
2019-07-15	Eingeleitet	Cowen	Market Perform
2019-04-17	Bestätigt	H.C. Wainwright	Buy
2018-08-07	Eingeleitet	Stifel	Buy
2018-07-23	Eingeleitet	H.C. Wainwright	Buy
2018-03-19	Bestätigt	Mizuho	Buy
2017-02-15	Eingeleitet	H.C. Wainwright	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-12-07	Eingeleitet	JMP Securities	Mkt Outperform
2015-12-07	Eingeleitet	Jefferies	Buy
2015-12-07	Eingeleitet	Leerink Partners	Outperform
2015-12-07	Eingeleitet	Sun Trust Rbsn Humphrey	Buy

Alle ansehen

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

Nov 17, 2024

Trading (WVE) With Integrated Risk Controls - Stock Traders Daily

Nov 17, 2024

Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com

Nov 17, 2024

Nov 16, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat

Nov 16, 2024

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com

Nov 15, 2024

WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 15, 2024

What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat

Nov 15, 2024

Wave Life Sciences to Present at Jefferies London Healthcare Conference - GlobeNewswire

Nov 15, 2024

What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat

Nov 15, 2024

US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St

Nov 15, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance

Nov 15, 2024

Equities Analysts Offer Predictions for WVE FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 14, 2024

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 14, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - MarketBeat

Nov 14, 2024

Nov 13, 2024

WaVe Life Sciences's SWOT analysis: RNA editing stock faces pivotal year - Investing.com

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 By Investing.com - Investing.com Nigeria

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 - Investing.com India

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook By Investing.com - Investing.com Australia

Nov 13, 2024

Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart

Nov 13, 2024

Wave Life Sciences (NASDAQ:WVE) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 13, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook - Investing.com

Nov 13, 2024